CTI Trademark

Trademark Overview

On Wednesday, August 2, 2000, a trademark application was filed for CTI with the United States Patent and Trademark Office. The USPTO has given the CTI trademark a serial number of 76976598. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 27, 2024. This trademark is owned by Cell Therapeutics, Inc.. The CTI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical, medical and laboratory research services in the field of pharmaceuticals, cancer, genetic disorders and gene therapy; providing information in the field of pharmaceuticals, medicine, cancer, genetic disorders and gene therapy[; providing an online magazine in the fields of pharmaceuticals, medicine, cancer, genetic disorders and gene therapy;] and consultation related to the foregoing
cti

General Information

Serial Number76976598
Word MarkCTI
Filing DateWednesday, August 2, 2000
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 27, 2024
Registration Number2854845
Registration DateTuesday, June 15, 2004
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 29, 2001

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical, medical and laboratory research services in the field of pharmaceuticals, cancer, genetic disorders and gene therapy; providing information in the field of pharmaceuticals, medicine, cancer, genetic disorders and gene therapy[; providing an online magazine in the fields of pharmaceuticals, medicine, cancer, genetic disorders and gene therapy;] and consultation related to the foregoing

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 27, 2024
Primary Code042
First Use Anywhere DateThursday, November 1, 2001
First Use In Commerce DateThursday, November 1, 2001

Trademark Owner History

Party NameCTI BIOPHARMA CORP.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98121
Party NameCell Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119
Party NameCell Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119
Party NameCell Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Trademark Events

Event DateEvent Description
Wednesday, May 16, 2001NOTICE OF PUBLICATION
Wednesday, December 20, 2000ASSIGNED TO EXAMINER
Thursday, January 11, 2001EXAMINER'S AMENDMENT MAILED
Tuesday, January 23, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 29, 2001PUBLISHED FOR OPPOSITION
Monday, July 9, 2001EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 5, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 4, 2002PAPER RECEIVED
Wednesday, September 4, 2002SOU EXTENSION 1 FILED
Friday, September 27, 2002SOU EXTENSION 1 GRANTED
Tuesday, March 4, 2003PAPER RECEIVED
Tuesday, March 4, 2003SOU EXTENSION 2 FILED
Tuesday, May 13, 2003SOU EXTENSION 2 GRANTED
Friday, September 5, 2003PAPER RECEIVED
Friday, September 5, 2003SOU EXTENSION 3 FILED
Thursday, October 16, 2003SOU EXTENSION 3 GRANTED
Friday, March 5, 2004PAPER RECEIVED
Friday, March 5, 2004DIVISIONAL REQUEST RECEIVED
Friday, March 5, 2004USE AMENDMENT FILED
Thursday, March 25, 2004DIVISIONAL PROCESSING COMPLETE
Thursday, March 25, 2004STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 30, 2004ASSIGNED TO EXAMINER
Tuesday, June 15, 2004REGISTERED-PRINCIPAL REGISTER
Thursday, July 1, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 2, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, July 21, 2014TEAS SECTION 8 & 9 RECEIVED
Monday, August 4, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 4, 2014REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, April 8, 2004ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 15, 2010TEAS SECTION 8 & 15 RECEIVED
Thursday, July 1, 2010REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, August 4, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, May 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 6, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 6, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 6, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 4, 2014REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, May 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 6, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 6, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 14, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 14, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 12, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Thursday, June 15, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, December 27, 2024CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Related Keywords

cancer genetic disorders therapy pharmaceuticals gene providing field medicine magazine